KRYSTAL BIOTECH INC has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan KRYSTAL BIOTECH, INC. 401(K) PLAN
401k plan membership statisitcs for KRYSTAL BIOTECH, INC. 401(K) PLAN
| Measure | Date | Value |
|---|
| 2023 : KRYSTAL BIOTECH, INC. 401(K) PLAN 2023 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2023-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $6,195 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $20,283 |
| Total income from all sources (including contributions) | 2023-12-31 | $5,587,045 |
| Total loss/gain on sale of assets | 2023-12-31 | $0 |
| Total of all expenses incurred | 2023-12-31 | $938,672 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2023-12-31 | $867,930 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2023-12-31 | $4,204,427 |
| Value of total assets at end of year | 2023-12-31 | $9,883,263 |
| Value of total assets at beginning of year | 2023-12-31 | $5,248,978 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-12-31 | $70,742 |
| Total interest from all sources | 2023-12-31 | $3,048 |
| Total dividends received (eg from common stock, registered investment company shares) | 2023-12-31 | $0 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2023-12-31 | No |
| Was this plan covered by a fidelity bond | 2023-12-31 | Yes |
| Value of fidelity bond cover | 2023-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2023-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2023-12-31 | No |
| Contributions received from participants | 2023-12-31 | $2,773,590 |
| Participant contributions at end of year | 2023-12-31 | $52,264 |
| Participant contributions at beginning of year | 2023-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2023-12-31 | $215,636 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2023-12-31 | $6,195 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2023-12-31 | $20,283 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-12-31 | No |
| Value of net income/loss | 2023-12-31 | $4,648,373 |
| Value of net assets at end of year (total assets less liabilities) | 2023-12-31 | $9,877,068 |
| Value of net assets at beginning of year (total assets less liabilities) | 2023-12-31 | $5,228,695 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2023-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2023-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2023-12-31 | No |
| Value of interest in pooled separate accounts at end of year | 2023-12-31 | $9,733,799 |
| Value of interest in pooled separate accounts at beginning of year | 2023-12-31 | $5,215,272 |
| Interest on participant loans | 2023-12-31 | $3,048 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2023-12-31 | $97,200 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2023-12-31 | $33,706 |
| Net investment gain/loss from pooled separate accounts | 2023-12-31 | $1,379,570 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2023-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2023-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2023-12-31 | No |
| Contributions received in cash from employer | 2023-12-31 | $1,215,201 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2023-12-31 | $867,930 |
| Contract administrator fees | 2023-12-31 | $1,625 |
| Did the plan have assets held for investment | 2023-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2023-12-31 | No |
| Opinion of an independent qualified public accountant for this plan | 2023-12-31 | Unqualified |
| Accountancy firm name | 2023-12-31 | H2R CPA |
| Accountancy firm EIN | 2023-12-31 | 251031723 |
| 2022 : KRYSTAL BIOTECH, INC. 401(K) PLAN 2022 401k financial data |
|---|
| Total unrealized appreciation/depreciation of assets | 2022-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $20,283 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $2,841 |
| Total income from all sources (including contributions) | 2022-12-31 | $2,444,603 |
| Total loss/gain on sale of assets | 2022-12-31 | $0 |
| Total of all expenses incurred | 2022-12-31 | $333,134 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $284,722 |
| Value of total corrective distributions | 2022-12-31 | $18,986 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $3,162,539 |
| Value of total assets at end of year | 2022-12-31 | $5,248,978 |
| Value of total assets at beginning of year | 2022-12-31 | $3,120,067 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $29,426 |
| Total interest from all sources | 2022-12-31 | $24 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $0 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-31 | No |
| Was this plan covered by a fidelity bond | 2022-12-31 | Yes |
| Value of fidelity bond cover | 2022-12-31 | $500,000 |
| If this is an individual account plan, was there a blackout period | 2022-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
| Contributions received from participants | 2022-12-31 | $1,715,384 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2022-12-31 | $652,047 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2022-12-31 | $20,283 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2022-12-31 | $2,841 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
| Value of net income/loss | 2022-12-31 | $2,111,469 |
| Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $5,228,695 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $3,117,226 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
| Value of interest in pooled separate accounts at end of year | 2022-12-31 | $5,215,272 |
| Value of interest in pooled separate accounts at beginning of year | 2022-12-31 | $3,109,578 |
| Interest on participant loans | 2022-12-31 | $24 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2022-12-31 | $33,706 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2022-12-31 | $10,489 |
| Net investment gain/loss from pooled separate accounts | 2022-12-31 | $-717,960 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2022-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2022-12-31 | No |
| Contributions received in cash from employer | 2022-12-31 | $795,108 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-31 | $284,722 |
| Contract administrator fees | 2022-12-31 | $29,426 |
| Did the plan have assets held for investment | 2022-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-31 | No |
| Opinion of an independent qualified public accountant for this plan | 2022-12-31 | Unqualified |
| Accountancy firm name | 2022-12-31 | H2R CPA |
| Accountancy firm EIN | 2022-12-31 | 251031723 |
